ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT00925769
Brief Title: ATX Study:A Study of Avastin (Bevacizumab), Tarceva (Erlotinib) and Xeloda (Capecitabine) in Patients With Locally Advanced and/or Metastatic Pancreatic Cancer

First Submitted : April 15, 2009
First Submitted that Met QC Criteria : June 19, 2009
First Posted : June 22, 2009 (Estimate)

Results First Submitted : July 13, 2015
Results First Submitted that Met QC Criteria : July 13, 2015
Results First Posted : August 7, 2015 (Estimate)

Last Update Submitted that Met QC Criteria : July 13, 2015
Last Update Posted : August 7, 2015 (Estimate)